A carregar...
Valsartan Orodispersible Tablets: Formulation, In vitro/In vivo Characterization
Valsartan orodispersible tablets have been developed at 40-mg dose, with the intention of facilitating administration to patients experiencing problems with swallowing and hopefully, improving its poor oral bioavailability. Work started with selecting drug compatible excipients depending on differen...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2850465/ https://ncbi.nlm.nih.gov/pubmed/20112137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-009-9354-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|